Why the study?
Post-exercise hypotension predicts long-term exercise-induced blood pressure lowering, and local vascular bioactive lipids may play a role.
Does a single bout of endurance exercise induce post-exercise hypotension and changes in bioactive lipids that can serve as predictors in healthy volunteers?
Does a single bout of endurance exercise induce post-exercise hypotension and changes in bioactive lipids that can serve as predictors in healthy volunteers?
15-HETE may serve as a specific biomarker for post-exercise hypotension, potentially helping to identify patients who will benefit from exercise in hypertension therapy.
Answers are grounded in this paper and cite their sources.
15-HETE correlation with PEH is hypothesis-generating in healthy volunteers; leaves open biomarker role in hypertension therapy.
Post-exercise hypotension (PEH) is the phenomenon of lowered blood pressure after a single bout of exercise. Only a fraction of people develops PEH but its occurrence correlates well with long-term effects of sports on blood pressure. Therefore, PEH has been suggested as a suitable predictor for the effectivity of exercise as therapy in hypertension. Local vascular bioactive lipids might play a potential role in this context. We performed a cross-over clinical pilot study with 18 healthy volunteers to investigate the occurrence of PEH after a single short-term endurance exercise. Furthermore, we investigated the plasma lipid profile with focus on arachidonic acid (AA)-derived metabolites as potential biomarkers of PEH. A single bout of ergometer cycling induced a significant PEH in healthy volunteers with the expected high inter-individual variability. Targeted lipid spectrum analysis revealed significant upregulation of several lipids in the direct post-exercise phase. Among these changes, only 15- hydroxyeicosatetranoic acid (HETE) correlated significantly with the extent of PEH but in an AA-independent manner, suggesting that 15-HETE might act as specific PEH-marker. Our data indicate that specific lipid modulation might facilitate the identification of patients who will benefit from exercise activity in hypertension therapy. However, larger trials including hypertonic patients are necessary to verify the clinical value of this hypothesis.
No takes yet. Share an insight, caveat, or question.
Wolters et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: